Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NH › Nashua › NPI 1598700940
Hospital

Southern New Hampshire Medical Center

Southern New Hampshire Medical Center was paid $22.25M by Medicaid between Jan 2018 and Dec 2024, across 276 billing codes. Its largest line is 99285, emergency room visit (most serious) — 18% of everything it billed.

33Billing provider infoSOUTHERN NEW HAMPSHIRE MEDICAL CENTER
NASHUA, NH 03060
33aNPI1598700940assigned 06/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$22.25M
24GClaims695,194
24DCodes billed276
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Hampshire

Rank by total paid#3 of 9
Median peer was paid$10.80M
This provider vs. median2.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018121,200$3.30M
2019134,853$3.66M
2020125,597$3.55M
2021142,261$4.28M
2022106,527$3.78M
202336,325$1.96M
2024incomplete28,431$1.72M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 18% 28,528 21,190 $3.91M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 39,592 31,158 $3.19M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 48,574 38,322 $3.02M
74177 Computed tomography, abdomen and pelvis; with contrast material 5.2% 3,484 2,749 $1.16M
70450 Computed tomography, head or brain; without contrast material 2.7% 4,237 3,279 $592K
G0378 Hospital observation service, per hour 2.2% 2,953 2,216 $480K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.7% 22,506 6,111 $385K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.6% 10,360 7,433 $347K
71046 Radiologic examination, chest; 2 views 1.5% 10,310 8,145 $329K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.5% 8,695 3,277 $329K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.4% 3,031 2,555 $316K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.3% 4,496 3,568 $300K
264 more codes
96375 Therapeutic injection; each additional sequential IV push 1.3% 6,437 $285K
80053 Comprehensive metabolic panel 1.2% 45,624 $278K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 1,036 $272K
72125 Computed tomography, cervical spine; without contrast material 1.1% 1,266 $234K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.0% 2,890 $229K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 903 $223K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 4,124 $215K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,651 $212K
90791 Psychiatric diagnostic evaluation <1% 4,444 $208K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 4,069 $206K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 44,034 $196K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 12,451 $189K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 461 $186K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,103 $184K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 11,624 $182K
96361 Intravenous infusion, hydration; each additional hour <1% 5,961 $167K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,522 $167K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 4,650 $119K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 653 $110K
84443 Thyroid stimulating hormone (TSH) <1% 10,420 $108K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,658 $107K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,707 $107K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,610 $99K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 406 $98K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,819 $97K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,809 $96K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 525 $87K
71045 Radiologic examination, chest; single view <1% 4,628 $83K
97161 <1% 2,182 $83K
96376 <1% 1,817 $82K
80061 Lipid panel <1% 8,251 $79K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 1,354 $77K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,454 $74K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,437 $69K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,903 $66K
70551 Magnetic resonance imaging, brain; without contrast material <1% 295 $65K
74018 <1% 1,763 $62K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,443 $60K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,681 $60K
97162 <1% 1,510 $58K
73630 <1% 1,743 $58K
93351 <1% 341 $57K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,630 $54K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,375 $54K
73610 <1% 1,427 $52K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 577 $52K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 2,334 $49K
72100 <1% 1,227 $49K
93971 <1% 1,023 $46K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,047 $45K
71250 <1% 543 $45K
84484 <1% 9,879 $44K
83690 <1% 11,189 $44K
73562 <1% 1,290 $43K
73130 <1% 953 $43K
85027 <1% 9,851 $42K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 4,984 $42K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,168 $41K
59050 <1% 1,168 $41K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,812 $37K
84703 <1% 7,091 $34K
76775 <1% 500 $33K
80048 Basic metabolic panel (calcium, ionized) <1% 6,471 $31K
73030 <1% 1,080 $30K
76830 Ultrasound, transvaginal <1% 385 $30K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 128 $29K
83036 Hemoglobin; glycosylated (A1C) <1% 4,437 $29K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 227 $27K
73110 <1% 752 $27K
83880 <1% 1,816 $27K
76642 <1% 498 $25K
84702 <1% 2,127 $24K
74019 <1% 623 $23K
59025 Fetal non-stress test <1% 1,032 $23K
87040 <1% 2,430 $21K
82728 <1% 2,150 $21K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 449 $21K
86850 <1% 2,701 $20K
87077 <1% 3,430 $20K
97035 <1% 1,930 $19K
87081 <1% 4,135 $19K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 72 $19K
87186 <1% 3,085 $19K
85730 <1% 5,749 $18K
86803 <1% 1,835 $18K
76536 <1% 289 $18K
81001 <1% 10,079 $17K
87070 <1% 2,713 $17K
82607 <1% 2,078 $17K
84439 <1% 2,667 $17K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,705 $16K
82657 <1% 1,265 $16K
83721 <1% 2,577 $16K
85610 <1% 7,368 $16K
88342 <1% 1,208 $14K
87808 <1% 1,268 $14K
J2704 Injection, propofol, 10 mg <1% 6,031 $14K
83735 <1% 3,562 $13K
87340 <1% 1,745 $13K
94060 <1% 224 $13K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 711 $12K
36415 Collection of venous blood by venipuncture <1% 23,065 $12K
70486 <1% 57 $11K
70496 <1% 42 $11K
76770 <1% 99 $11K
87653 <1% 552 $11K
73140 <1% 356 $11K
87641 <1% 414 $11K
83550 <1% 1,601 $10K
87147 <1% 1,907 $10K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 33 $9K
80076 <1% 1,533 $9K
86140 <1% 2,442 $9K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 231 $9K
A9585 Injection, gadobutrol, 0.1 ml <1% 1,392 $9K
80050 General health panel <1% 1,228 $9K
83540 <1% 1,881 $9K
83970 <1% 296 $9K
99213 Doctor's office visit, returning patient (routine) <1% 324 $9K
86618 <1% 823 $8K
82746 <1% 844 $8K
87807 <1% 883 $8K
93970 <1% 90 $8K
94729 <1% 257 $8K
86003 <1% 145 $8K
94726 <1% 241 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,318 $7K
81003 <1% 7,496 $7K
88304 <1% 312 $7K
87205 <1% 2,234 $7K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 493 $7K
82784 <1% 726 $7K
83516 <1% 576 $7K
93320 <1% 112 $7K
93325 <1% 112 $7K
85379 <1% 990 $6K
82570 <1% 1,735 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 790 $6K
73502 <1% 201 $6K
86762 <1% 575 $6K
70498 <1% 29 $6K
86706 <1% 758 $6K
86592 <1% 1,813 $6K
83605 <1% 914 $6K
86038 <1% 601 $5K
86900 <1% 2,454 $5K
85651 <1% 2,080 $5K
87522 Neg quan hep c or qual rna <1% 158 $5K
86901 <1% 2,452 $5K
88341 <1% 109 $5K
83789 <1% 375 $5K
82043 <1% 1,213 $4K
45388 <1% 14 $4K
96367 <1% 34 $4K
84403 <1% 190 $4K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 260 $4K
86364 <1% 118 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,449 $4K
12001 <1% 62 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,818 $4K
84100 <1% 1,323 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 38 $4K
80074 <1% 113 $4K
84153 <1% 348 $4K
99219 <1% 16 $3K
97165 <1% 92 $3K
73080 <1% 110 $3K
87640 <1% 208 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,093 $3K
82550 <1% 784 $3K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 742 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 542 $3K
82248 <1% 836 $3K
71101 <1% 64 $3K
93976 <1% 33 $3K
87210 <1% 1,002 $3K
76870 <1% 36 $2K
82805 <1% 80 $2K
93246 <1% 34 $2K
77080 <1% 29 $2K
90715 <1% 150 $2K
97802 <1% 39 $2K
93923 <1% 30 $2K
82947 <1% 545 $2K
81025 <1% 351 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 837 $1K
97750 <1% 89 $1K
97803 <1% 130 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,332 $1K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 41 $1K
85652 <1% 674 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,203 $1K
82565 <1% 345 $1K
96368 <1% 29 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,380 $1K
86708 <1% 126 $1K
97010 <1% 505 $1K
84146 <1% 60 $1K
51701 <1% 72 $969.14
84480 <1% 88 $947.56
86704 <1% 106 $932.27
84156 <1% 337 $892.45
77066 Tomosynthesis, mammo <1% 12 $856.15
J2270 Injection, morphine sulfate, up to 10 mg <1% 792 $722.21
88312 <1% 30 $600.43
82785 <1% 40 $598.30
86431 <1% 132 $574.97
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,216 $534.26
51798 <1% 33 $521.54
73090 <1% 20 $501.45
84402 <1% 24 $489.97
86787 <1% 44 $478.89
85007 <1% 349 $474.77
82950 <1% 172 $461.62
72070 <1% 16 $415.79
82105 <1% 35 $398.40
83615 <1% 81 $378.62
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 155 $375.49
80164 <1% 51 $355.25
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 606 $318.40
L4361 Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf <1% 14 $309.73
87015 <1% 60 $306.66
85046 <1% 126 $306.43
87106 <1% 40 $295.69
87427 <1% 13 $278.73
84481 <1% 21 $270.37
88142 <1% 17 $262.85
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 18 $259.62
82150 <1% 63 $237.73
J2060 Injection, lorazepam, 2 mg <1% 541 $235.42
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 392 $235.39
80178 <1% 54 $231.94
82803 <1% 21 $216.98
84425 <1% 14 $179.06
J1250 Injection, dobutamine hydrochloride, per 250 mg <1% 58 $171.89
84550 <1% 51 $165.32
81015 <1% 79 $158.66
82247 <1% 40 $157.93
J1644 Injection, heparin sodium, per 1000 units <1% 190 $124.28
87045 <1% 14 $123.51
84436 <1% 26 $118.61
83655 <1% 12 $115.50
86141 <1% 12 $115.07
87046 <1% 27 $108.44
81005 <1% 66 $105.22
J2550 Injection, promethazine hcl, up to 50 mg <1% 168 $97.34
83525 <1% 14 $96.45
99217 <1% 14 $73.56
84520 <1% 28 $68.09
82977 <1% 12 $67.45
86308 <1% 14 $53.80
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 226 $30.46
J0461 Injection, atropine sulfate, 0.01 mg <1% 16 $28.18
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 17 $22.18
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 32 $17.65
85018 <1% 13 $17.62
J1630 Injection, haloperidol, up to 5 mg <1% 13 $8.75
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 37 $7.56
80354 <1% 197 $5.36
80348 <1% 197 $5.36
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 272 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 288 $0.00
G8990 Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals 0% 18 $0.00
G8991 Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCHUGH, COLIN (PRESIDENT/CEO)
Same official

Other billing entities under MCHUGH, COLIN

Full network →
ProviderLocationPaid
Foundation Medical Partners INCNashua, NH$5.81M
Foundation Medical Partners INCNashua, NH$326K
Southern New Hampshire Medical CenterNashua, NH$54K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.